Podcasts Archives

Mergers & Acquisitions

Drinks With The Deal: Freshfields' Jenny Hochenberg Discusses the Demands of the Job

By David Marcus

Published: March 9th, 2023

Freshfields' Jenny Hochenberg discusses her unusual path to becoming an M&A lawyer, the challenges of being a young partner and managing the intensity of the job.

Podcasts

Fresh Start: CohnReznick's Sherman, The Deal's Meagher Talk Distressed SPACs

By Stephanie Gleason

Published: March 6th, 2023

The pair discuss how companies that went public a year ago are winding up in Chapter 11.

Activism

Activist Investing Today: Gojkovich Talks Universal Contests, Proxy Advisers, 'Activated' Managers

By Ronald Orol

Published: March 3rd, 2023

Lauren Gojkovich, who switched sides to advise activists at LDG Advisory, discusses prospects for 'activated' historically passive institutions and why the universal card in contests could reduce proxy adviser influence.

Mergers & Acquisitions

Drinks With The Deal: Skadden's Nijjar Discusses Tech M&A Boom, Memories of Bear Stearns

By David Marcus

Published: February 23rd, 2023

On the most recent Drinks With The Deal, Skadden M&A partner Sonia Nijjar discusses her work on the sale of Bear Stearns, her transition to a tech M&A practice and advising Activision and Elon Musk last year.

Activism

Activist Investing Today: ZMH's Hassan Talks Nominations, Masimo, Disney

By Ronald Orol

Published: February 23rd, 2023

Waheed Hassan, who has advised on major proxy contests at Huntsman, U.S. Foods and LivePerson, discusses activist director recruitment, Masimo's now removed bylaws and Nelson Peltz's battle at Disney.

Podcasts

Drinks With The Deal: Nixon Peabody's O'Keefe on Advising Founders

By David Marcus

Published: February 16th, 2023

Amy O'Keefe, an M&A and PE partner at Nixon Peabody in Boston, discusses the rewards and challenges of advising founders on the sales of their companies on this week's Drinks With The Deal podcast.

Mergers & Acquisitions

Talking M&A: Trends in Healthtech and Biotech M&A

By Deal Contributors

Published: February 7th, 2023

Baker McKenzie partner Aarthi Belani, AbbVie head of immunology business development and acquisitions Rachel Strick, Flare Capital Partners co-founder Michael Greeley and Patient Square Capital founding partner Neel Varshney share their insights on M&A trends in the sectors for the third episode of the Talking M&A podcast.

Mergers & Acquisitions

Drinks With The Deal: Wilson's Pavri on Dealmaking in Silicon Valley

By David Marcus

Published: February 2nd, 2023

Rezwan Pavri, a securities and M&A partner at Wilson Sonsini in Palo Alto, talks about balancing the two practices and the challenges his clients are facing in the most recent Drinks With The Deal podcast.

Activism

Activist Investing Today: White & Case’s Matthews, Tolani on Insurgents, Deals

By Ronald Orol

Published: January 26th, 2023

The U.K.-based attorneys, who advise both activists and companies, explain why they are seeing a trend of insurgent managers partnering with PE to try to buy companies they previously targeted with agitation campaigns.

News & Media

Drinks With The Deal: Freshfields' Jenny Hochenberg Discusses the Demands of the Job

Fresh Start: CohnReznick's Sherman, The Deal's Meagher Talk Distressed SPACs

Activist Investing Today: Gojkovich Talks Universal Contests, Proxy Advisers, 'Activated' Managers

Drinks With The Deal: Skadden's Nijjar Discusses Tech M&A Boom, Memories of Bear Stearns

Activist Investing Today: ZMH's Hassan Talks Nominations, Masimo, Disney

Drinks With The Deal: Nixon Peabody's O'Keefe on Advising Founders

Talking M&A: Trends in Healthtech and Biotech M&A

Drinks With The Deal: Wilson's Pavri on Dealmaking in Silicon Valley

Activist Investing Today: White & Case’s Matthews, Tolani on Insurgents, Deals

Join our community of dealmakers and advisers